Terumo India News and Activities

Terumo India is owned by Terumo.

Terumo is one of the...

• Forbes Global 2000 (#1242);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Terumo is a company listed under the stock ticker 4543 (JP).

Terumo has a direct presence in 7 countries.

Terumo has 8 subsidiaries including OrganOx, Terumo Aortic and Terumo BCT.

They are in:

• Medical Equipment89%
• Pharmaceuticals11%

View the org chart displaying its 15 main executives

Most searched biographies at Terumo India

• Shishir Agarwal, Managing Director and Director
• Virender Bansal, Director, Finance, Supply Chain, IT and Legal
• Vikram Duggal, Deputy General Manager, Strategic Projects

Create your alert
to follow the executive moves at Terumo India.

Terumo has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Terumo India

• Terumo Blood and Cell Technologies kicks off U.S. launch of Reveos Automated Blood Processing System with Blood Centers of America | Terumo
• Terumo Group Associates Celebrate Terumo Patient’s Day 2024 | Terumo
• MicroVention Rebrands to Terumo Neuro - Reflects Expanded Focus and Strategic Growth | Terumo
• News | | Terumo
• Terumo Blood and Cell Technologies and Charles River Demonstrate Versatility of FINIA Automated Cell and Gene Therapy Fill and Finish Platform | Terumo
• Terumo India Wins Big For Its Health & Wellbeing Initiatives | Terumo
• MicroVention Announces Release of CLinical EValuation of WEB™ 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured Aneurysms | Terumo
• Terumo Establishes Corporate Venture Capital “Terumo Ventures” | Terumo
• NICE PUBLISHES NEW GUIDANCE SUPPORTING THE USE OF HOLMIUM-166 SELECTIVE INTERNAL RADIATION THERAPY FOR UNRESECTABLE ADVANCED HEPATOCELLULAR CARCINOMA | Terumo
• Terumo Blood and Cell Technologies celebrates 60 years as a community-first Colorado company | Terumo
• View more press releases Close

Social media about Terumo India

• Terumo India on Wikipedia, Google News & Yahoo Finance
• Terumo India on LinkedIn, X (Twitter) & YouTube